Show simple item record

dc.contributor.authorFunnell, S. G.P.
dc.contributor.authorDowling, W. E.
dc.contributor.authorMuñoz-Fontela, C.
dc.contributor.authorGsell, P. S.
dc.contributor.authorIngber, D. E.
dc.contributor.authorHamilton, G. A.
dc.contributor.authorDelang, L.
dc.contributor.authorRocha-Pereira, J.
dc.contributor.authorKaptein, S.
dc.contributor.authorDallmeier, K. H.
dc.contributor.authorNeyts, J.
dc.contributor.authorRosenke, K.
dc.contributor.authorde Wit, E.
dc.contributor.authorFeldmann, H.
dc.contributor.authorMaisonnasse, P.
dc.contributor.authorLe Grand, R.
dc.contributor.authorFrieman, M. B.
dc.contributor.authorColeman, C. M.
dc.date.accessioned2020-09-10T18:26:55Z
dc.date.available2020-09-10T18:26:55Z
dc.date.issued2020-12-01
dc.identifier.urihttp://hdl.handle.net/10713/13675
dc.description.sponsorshipHorizon 2020 Framework Programmeen_US
dc.description.urihttps://doi.org/10.1038/s41467-020-17907-wen_US
dc.language.isoen_USen_US
dc.publisherSpringer Natureen_US
dc.relation.ispartofNature Communicationsen_US
dc.subject.meshChloroquineen_US
dc.subject.meshCOVID-19en_US
dc.subject.meshHydroxychloroquineen_US
dc.titleEmerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patientsen_US
dc.typeArticleen_US
dc.identifier.doi10.1038/s41467-020-17907-w
dc.identifier.eid2-s2.0-85089895635
dc.identifier.scopusidSCOPUS_ID:85089895635
dc.source.volume11
dc.source.issue1
dc.identifier.eissn20411723
dc.identifier.journalNature Communications


This item appears in the following Collection(s)

Show simple item record